戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ectious particles through a process known as pseudotyping.
2 ssed by vesicular stomatitis virus G-protein pseudotyping.
3 sion and encapsidation, and envelope protein pseudotyping.
4 teins were screened for efficient FIV vector pseudotyping and hepatocyte transduction.
5  targeted retroviruses, which combines viral pseudotyping and molecular engineering approaches to ena
6 e kinetics of thymic infection, modulated by pseudotyping and viral interference, facilitates a stepw
7 RS-CoV-2-anti-Spike neutralizing capacity by pseudotyping assay in 124 individuals; neutralizing tite
8 airs to NAb in donor plasma by using a virus pseudotyping assay, thereby providing an ideal setting t
9 e chimeric Envs were evaluated using a virus-pseudotyping assay.
10                                              Pseudotyping by the glycoprotein of vesicular stomatitis
11              Truncation of the gp41 tail, or pseudotyping by vesicular stomatitis virus glycoprotein,
12                                              Pseudotyping by VSV-G markedly suppressed the requiremen
13 es and thymomas suggested that the change in pseudotyping characteristics was not the result of the e
14        Additional experiments indicated that pseudotyping contributed to the elevated polytropic viru
15 or localization and innate activation, fiber pseudotyping did not significantly change the outcome of
16 s proof-of-concept, we demonstrate efficient pseudotyping, entry, and neutralization of HiBiT-PsVLPs.
17 cells demonstrated that BCRs specific to the pseudotyping envelope proteins mediate viral entry, enab
18 e molecules varies, depending on the type of pseudotyping envelope proteins.
19 ed a single-cycle form of HIV-1, prepared by pseudotyping envelope-defective HIV-1 plasmids with the
20 ant virions; similar results are obtained in pseudotyping experiments using wild-type or truncated HI
21 ines in vitro in co-culture, infectivity and pseudotyping experiments.
22 ed virus with natural lung tropism; however, pseudotyping feline immunodeficiency virus (FIV)-based l
23                                              Pseudotyping FIV with GP64 from three species of baculov
24                                  Conversely, pseudotyping FIV with the envelope protein from influenz
25 of marker genes; control of synaptic spread; pseudotyping for infection of selected cells; addition o
26 onnative viral particles in a process termed pseudotyping; however, the molecular mechanisms governin
27 h amplification on complementing cell lines, pseudotyping if desired, purification by ultracentrifuga
28                  This shows the potential of pseudotyping in expanding the utility of lentiviral vect
29         Finally, these studies indicate that pseudotyping in the HIV-1 virion-based fusion assay may
30 xed retroviral infections frequently exhibit pseudotyping, in which the genome of one virus is packag
31                  Having determined that this pseudotyping increased the efficiency of gene transfer t
32                                        Virus pseudotyping is a useful and safe technique for studying
33                                     Although pseudotyping is widely used for engineering chimeric vir
34                  Despite the fact that viral pseudotyping is widely used, what makes a virus/glycopro
35                However, this process, termed pseudotyping, is poorly understood at the molecular leve
36 did not exhibit a comparable high titer upon pseudotyping, it led to a significant increase in distal
37  rodent fibroblasts but are still capable of pseudotyping lentiviral and oncoretroviral vectors.
38 ght be suitable as alternatives to VSV-G for pseudotyping lentivirus vectors.
39                                        Thus, pseudotyping might account for the PERV transmission pre
40 ic stage, a dramatic change in the extent of pseudotyping occurred in thymuses.
41                              We suggest that pseudotyping occurs through specific lipid-protein inter
42 n of mice with an ecotropic virus results in pseudotyping of intact endogenous viruses that have not
43    However, this transmission was due to the pseudotyping of PERV-C (a virus without human tropism) b
44  provided via selection of glycoproteins for pseudotyping of the lentiviral particles.
45         We have previously demonstrated that pseudotyping of the nonprimate equine infectious anemia
46                                 Furthermore, pseudotyping of the polytropic MuLV genome within ecotro
47                     Marked amplification and pseudotyping of the polytropic MuLV were also observed i
48 ll Host & Microbe, three papers describe the pseudotyping of vesicular stomatitis virus (VSV) with th
49    This process of complementation, known as pseudotyping, often can occur even when the glycoprotein
50 LVs in coinfected mice may be facilitated by pseudotyping or, alternatively, by transactivation of th
51                             We conclude that pseudotyping provides a useful means to manipulate viral
52 investigated the possibility of "genetically pseudotyping" replication-competent MLV by replacing the
53 inding and fusion to CD13 is a candidate for pseudotyping retroviral envelopes or modifying other vir
54                                              Pseudotyping retrovirus and lentivirus vectors with diff
55              Here, we present a strategy for pseudotyping retroviruses with peptide-major histocompat
56                                              Pseudotyping SIVmac/HIV-1 overcame this deficiency, sugg
57                                    We used a pseudotyping strategy to investigate the cell biology of
58 n antifiloviral screening system, based on a pseudotyping strategy, and its application in the discov
59                                   Using this pseudotyping strategy, the involvement of the ubiquitin-
60                                        Using pseudotyping strategy, we produced double-stranded (dsAA
61                                              Pseudotyping studies show that the differential tissue t
62                                      The HSV pseudotyping system established in this study presents a
63 ur knowledge, this is the first time the VSV pseudotyping system has been successfully extended beyon
64                                     This HSV pseudotyping system pioneered in this work opens doors f
65                                   The AcMNPV pseudotyping system provides an efficient and powerful m
66 e using a human immunodeficiency virus-based pseudotyping system to identify specific regions that af
67                             We have used the pseudotyping system to study the tropism of viruses bear
68 e development and optimization of a suitable pseudotyping system.
69 try by using a recently developed retroviral pseudotyping system.
70  affect host cell properties and recombinant pseudotyping systems in which filovirus structural glyco
71                           Current retroviral pseudotyping systems using the HTLV-1 envelope generate
72 se modified retroviral vectors and the VSV-G pseudotyping technique constitute significant improvemen
73  the potential benefits which may arise from pseudotyping the HIV-1 lentiviral vector with its homolo
74  DC-directed specificity is achieved through pseudotyping the vector with an engineered Sindbis virus
75       Despite this, mixed infections lead to pseudotyping, the association of the viral cores of one
76 ses from cDNA, amplification of the viruses, pseudotyping them with EnvA or EnvB and concentration an
77 ein (Ebo-GP), we have developed a system for pseudotyping these glycoproteins into murine leukemia vi
78                This defect can be rescued by pseudotyping these mutant viruses with vesicular stomati
79    We suggest that these two regions dictate pseudotyping through interactions with specific lipid en
80                                        Using pseudotyping to assess Env function in single-round infe
81      We describe here an improved system for pseudotyping using a defective human immunodeficiency vi
82 truncating the gp41 cytoplasmic domain or by pseudotyping viruses with the glycoprotein of vesicular
83                  In this report, we describe pseudotyping which occurred among the polytropic and eco
84 zation in vitro can be partially bypassed by pseudotyping with Ad45 fiber protein, indicating that a
85 of CyPA-deficient virions is not restored by pseudotyping with Env of amphotropic murine leukemia vir
86 rions and that this block can be reversed by pseudotyping with heterologous retroviral envelope glyco
87 ly developed targeting lentiviral vectors by pseudotyping with modified Sindbis virus envelope protei
88 nd confocal microscopy, we demonstrated that pseudotyping with rabies virus envelope glycoprotein (RV
89 rotrophin receptor), thus demonstrating that pseudotyping with RV-G targets lentiviral vectors for tr
90                            In vivo, lentiVLP pseudotyping with the gp160 envelope or with a combinati
91                                  Remarkably, pseudotyping with the HAdV-5 fiber and/or penton RGD loo
92 , transient HIV-1 expression system based on pseudotyping with the vesicular stomatitis virus glycopr
93                                              Pseudotyping with the vesicular stomatitus virus G (VSV-
94 importance of high titer retroviral vectors, pseudotyping with VSV-G protein, and in situ selection.
95 f complete endogenous retrovirus genomes via pseudotyping within exogenous retroviral virions.